ARSENAULT KAITLYN 4
4 · Skye Bioscience, Inc. · Filed Feb 26, 2025
Insider Transaction Report
Form 4
ARSENAULT KAITLYN
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-24+150,000→ 150,000 totalExercise: $2.89Exp: 2035-02-25→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over the four year period beginning February 21, 2025.